Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 1/2 2Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 2Hyperthermia 2Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Colonic Neoplasms 1

Interventions

Gemcitabine 15pembrolizumab 13Doxorubicin 13Radiotherapy 12Docetaxel 9Nivolumab 8Filgrastim 7Cyclophosphamide 7pazopanib 6Ifosfamide 6130-nm albumin-bound paclitaxel 5Temozolomide 4Irinotecan 4Ipilimumab 4Imatinib Mesylate 4Albumin-Bound Paclitaxel 4talimogene laherparepvec 3surufatinib 3pegfilgrastim 3eribulin 3atezolizumab 3Vinorelbine 3Sirolimus 3Peripheral Blood Stem Cell Transplantation 3PM 01183 3Drug Therapy 3Cisplatin 3toripalimab 2spartalizumab 2selinexor 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Sarcoma × Diathermy × Clear all
NCT01904565 2015-09-02

HYPROSAR

Kantonsspital Aarau

Phase 1/2 Unknown
26 enrolled
Sarcoma

Hyperthermia, Sarcoma

NCT00093509 2014-09-01

MRI Sarcoma Non Invasive Thermometry

Duke University

Phase 1/2 Completed
15 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡